Angioedema caused by bupropion treatment

Area of Science:

• Pharmacology
• Clinical Medicine
• Dermatology

Background:

• Bupropion is frequently associated with cutaneous adverse reactions, including urticaria and rash, with an incidence of 1-4%.
• More severe adverse events such as seizures and angioedema are less common but can be dose-dependent.
• Rarely, bupropion may trigger a serum sickness-like reaction characterized by fever, arthralgia, and myalgia.

Purpose of the Study:

• To report a case of angioedema and arthralgia associated with bupropion use for smoking cessation.
• To review the literature on bupropion-induced hypersensitivity reactions.
• To discuss recommendations for safer bupropion prescribing in light of recent concerns.

Main Methods:

• A case study of a 30-year-old male patient presenting with rash, angioedema, and arthralgia after 19 days of bupropion treatment.
• Review of existing literature on bupropion adverse effects, focusing on hypersensitivity reactions.
• Analysis of management strategies and prescribing recommendations.

Main Results:

• The patient experienced rash, angioedema, and arthralgia, consistent with a hypersensitivity reaction to bupropion.
• Symptomatic improvement occurred within 3 hours of initiating antihistamines and steroids.
• Complete resolution of symptoms was achieved within 3 days after discontinuing bupropion.

Conclusions:

• Bupropion can induce hypersensitivity reactions, including angioedema and arthralgia, which are treatable with standard medical interventions.
• Discontinuation of the causative agent is crucial for managing bupropion-induced hypersensitivity.
• Clinicians should be aware of the potential for serious adverse reactions and consider safer prescribing practices.